Cargando…
Monitoring Immune Dysfunction in Septic Patients: Toward Tailored Immunotherapy
Septic syndromes represent a major although largely under-recognized healthcare problem worldwide accounting for thousands of deaths every year [1–3]. Mortality remains high ranging from 20 % for sepsis to over 50 % for septic shock despite almost 20 years of anti-inflammatory clinical trials [1–3]....
Autores principales: | Venet, F., Lepape, A., Monneret, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121891/ http://dx.doi.org/10.1007/978-0-387-92278-2_8 |
Ejemplares similares
-
Monitoring Immune Dysfunction in Septic Patients: Toward Tailored Immunotherapy
por: Venet, F., et al.
Publicado: (2009) -
Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions
por: Venet, Fabienne, et al.
Publicado: (2011) -
A dynamic view of mHLA-DR expression in management of severe septic patients
por: Monneret, Guillaume, et al.
Publicado: (2011) -
Overexpression of PD-1-related molecules is associated with lymphocyte anergy, mortality, and development of nosocomial infections in septic shock patients
por: Guignant, C, et al.
Publicado: (2010) -
Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients
por: Turrel-Davin, Fanny, et al.
Publicado: (2010)